Application 204095
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 50MG BASE | No | No |
| 002 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 100MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204095-001 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | ||
| A204095-002 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2015-06-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2015-06-29 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2015-06-29 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204095-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204095-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | 2015-06-29 | 3a93d1ddd44b… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A204095-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A204095-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A204095-001 | AB | 1 | b00525d2431f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Breckenridge Pharmaceutical, Inc | 25bdfc41-c7cb-4d16-b6a8-f102f9b8c984 | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | Bryant Ranch Prepack | 56c9e8ee-1460-4a4c-8033-65d9afb358c8 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | Bryant Ranch Prepack | 593d340b-f49a-455b-aeb2-5a1eaf7b6cbe | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | A-S Medication Solutions | 5755f1b2-c10b-47f6-a08d-38d1c05bd353 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | Bryant Ranch Prepack | 5f349cc5-b803-462d-b323-d681bd1a02f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Pristiq Extended-Release | DESVENLAFAXINE SUCCINATE | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0f43610c-f290-46ea-d186-4f998ed99fce | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Preferred Pharmaceuticals Inc. | b4a5efab-3765-4ea5-a8cd-66e67e76c845 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | Preferred Pharmaceuticals Inc. | 453a5759-2f0d-421d-be78-81ab97c8ce77 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Preferred Pharmaceutical, Inc. | 4b786ea1-309d-440c-b091-38d6b1f7fbd3 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | Lupin Pharmaceuticals, Inc. | e96272a2-8f73-4fbe-a8d4-a78d4ad68831 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Coupler LLC | 325be002-4db2-40e9-e063-6394a90ae94e | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| desvenlafaxine | DESVENLAFAXINE SUCCINATE | DIRECT RX | b3ef2bb2-c336-2d57-e053-2995a90a5fe0 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | A-S Medication Solutions | 7ee04e8c-ce6c-450d-9122-2bffd170bfd7 | 2024-12-05 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Bryant Ranch Prepack | 5e78c812-7fe6-4a4e-8465-0415df2e9851 | 2024-11-01 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine Succinate | DESVENLAFAXINE SUCCINATE | Macleods Pharmaceuticals Limited | edf18b33-a226-44f8-9f42-c409e691ee64 | 2024-08-09 | Boxed warning, Warnings, Adverse reactions | Desvenlafaxine Succinate DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | A-S Medication Solutions | 88ac1206-864b-47a3-82ab-be83bc9532f3 | 2023-09-19 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | A-S Medication Solutions | b2a3edb8-ba64-4ead-b452-d6c8dbaba91d | 2023-02-17 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Proficient Rx LP | d4542c5e-f9e8-49c7-afa6-9dd4c4d485f2 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
| Desvenlafaxine | DESVENLAFAXINE SUCCINATE | Alembic Pharmaceuticals Limited | 5bd203d2-477e-4d12-a875-cb8009f42410 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | DESVENLAFAXINE SUCCINATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-4230 | Desvenlafaxine | desvenlafaxine | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-4230 | Desvenlafaxine | desvenlafaxine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-4231 | Desvenlafaxine | desvenlafaxine | Mylan Pharmaceuticals Inc | ANDA | Current |
| 0378-4231 | Desvenlafaxine | desvenlafaxine | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 68151-5295 | Desvenlafaxine | desvenlafaxine | Carilion Materials Management | ANDA | Current |
| 71335-0798 | Desvenlafaxine | desvenlafaxine | Bryant Ranch Prepack | ANDA | Current |
| 71335-0798 | Desvenlafaxine | desvenlafaxine | Bryant Ranch Prepack | ANDA | Current |